Showing results (171-180 of 209) with videos related to
Sort By:
Pageof 21
Diagnostics (Basel, Switzerland)|May 28, 2022
Utility of Contemporary Health Screening in the Diagnosis of Bladder CancerChung-Un Lee, Wan Song, Michael Jakun Koo, et al.Scientific Reports|April 8, 2024
Androgen deprivation alone versus combined with pelvic radiation for adverse events and quality of life in clinically node-positive prostate cancerTae Hoon Lee, Hongryull Pyo, Gyu Sang Yoo, et al.Urology|December 3, 2014
Incidence and management of extended-spectrum beta-lactamase and quinolone-resistant Escherichia coli infections after prostate biopsyWan Song, Seol Ho Choo, Hyun Hwan Sung, et al.Journal of Medical Imaging and Radiation Oncology|March 13, 2024
Hypofractionated radiation therapy combined with androgen deprivation therapy for high-risk localized prostate cancerTae Hoon Lee, Hongryull Pyo, Gyu Sang Yoo, et al.Journal of Cachexia, Sarcopenia and Muscle|March 7, 2025
Paradoxical Effect of Myosteatosis on the Immune Checkpoint Inhibitor Response in Metastatic Renal Cell CarcinomaJiwoong Yu, Hyeonju Ahn, Kyung Yeon Han, et al.The World Journal of Men'S Health|April 29, 2023
Nomogram Using Prostate Health Index for Predicting Prostate Cancer in the Gray Zone: Prospective, Multicenter StudyJae Hoon Chung, Jeong Hyun Kim, Sang Wook Lee, et al.European Urology Focus|September 27, 2022
Chromosomal Instability in Cell-free DNA as a Prognostic Biomarker of Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Deprivation TherapyChung Un Lee, Eunhae Cho, Junnam Lee, et al.Radiation Oncology Journal|July 1, 2024
Hypofractionated radiation therapy combined with androgen deprivation therapy for clinically node-positive prostate cancerTae Hoon Lee, Hongryull Pyo, Gyu Sang Yoo, et al.Cancer Letters|January 27, 2019
Epstein-Barr virus-coded miR-BART13 promotes nasopharyngeal carcinoma cell growth and metastasis via targeting of the NKIRAS2/NF-κB pathwayYuan-Ji Xu, Rui Zhou, Jing-Feng Zong, et al.Investigative and Clinical Urology|May 7, 2024
Comparative analysis of recurrence rates between intravesical gemcitabine and bacillus Calmette-Guérin induction therapy following transurethral resection of bladder tumors in patients with intermediate- and high-risk bladder cancer: A retrospective multicenter studyJoongwon Choi, Kyung Hwan Kim, Hyung Suk Kim, et al.Pageof 21